4//SEC Filing
Szyman Catherine M. 4
Accession 0001225208-24-005706
CIK 0001099800other
Filed
May 5, 8:00 PM ET
Accepted
May 6, 7:18 PM ET
Size
10.3 KB
Accession
0001225208-24-005706
Insider Transaction Report
Form 4
Szyman Catherine M
CVP, Critical Care & Vascular
Transactions
- Tax Payment
Common Stock
2024-05-04$85.25/sh−3,442$293,431→ 45,576.437 total - Tax Payment
Common Stock
2024-05-03$85.06/sh−479$40,744→ 43,222.437 total - Exercise/Conversion
Common Stock
2024-05-04+5,796→ 49,018.437 total - Exercise/Conversion
Performance Rights
2024-05-04−5,796→ 0 totalFrom: 2024-05-04Exp: 2028-05-03→ Common Stock (5,796 underlying)
Footnotes (1)
- [F1]On May 4, 2021, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 1, 2024, the Compensation and Governance Committee of the Board of Directors determined that 117.11% of the target number of shares would vest as of May 4, 2024, and the actual number of shares vested are reflected on this Form 4.
Documents
Issuer
Edwards Lifesciences Corp
CIK 0001099800
Entity typeother
Related Parties
1- filerCIK 0001438538
Filing Metadata
- Form type
- 4
- Filed
- May 5, 8:00 PM ET
- Accepted
- May 6, 7:18 PM ET
- Size
- 10.3 KB